Krystal Biotech (KRYS) Other Non-Current Assets (2018 - 2026)

Krystal Biotech has disclosed Other Non-Current Assets across 9 years of filings, most recently posting $300000.0 for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $300000.0, up 37.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $300000.0 (up 37.61% YoY), and the FY2025 annual result was $287000.0, up 24.24% from the prior year.
• Other Non-Current Assets came in at $300000.0 for Q1 2026 at Krystal Biotech, up from $287000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $402000.0 in Q1 2023 to a low of $126000.0 in Q2 2024.
• The 5-year median for Other Non-Current Assets is $231000.0 (2024), against an average of $245352.9.
• Across the five-year window, Other Non-Current Assets soared 337.84% in 2022 and slumped 55.79% in 2024, its largest moves.
• Krystal Biotech's Other Non-Current Assets stood at $324000.0 in 2022, then retreated by 18.83% to $263000.0 in 2023, then dropped by 12.17% to $231000.0 in 2024, then gained by 24.24% to $287000.0 in 2025, then climbed by 4.53% to $300000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $300000.0 (Q1 2026), $287000.0 (Q4 2025), and $333000.0 (Q3 2025), per Business Quant data.